Company Valuation: Amerise Biosciences Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2020 2021 2022 2023 2024 2025
Market Cap 1 54.18 109 89.85 46.25 43.61 60.12
Change - 101.22% -17.58% -48.53% -5.71% 37.88%
Enterprise Value (EV) 1 53.93 108.8 90.55 47.01 43.39 59.9
Change - 101.8% -16.79% -48.08% -7.7% 38.04%
P/E -36.3x -32.3x 16.4x -41.3x -29.8x 1,056x
PBR 1x 2.14x 1.59x 0.84x 0.81x 1.12x
PEG - -0x -0x 0x -1x -10x
Capitalization / Revenue 9,465x -64.5x 0.94x 526x 121x 32x
EV / Revenue 9,421x -64.4x 0.95x 534x 121x 31.9x
EV / EBITDA - - - - - -
EV / EBIT -36.4x -32.3x 16.5x -28.4x -29.8x 768x
EV / FCF 1.09x -40.6x -62.7x -40.2x -38x 1.95x
FCF Yield 91.8% -2.46% -1.6% -2.49% -2.63% 51.3%
Dividend per Share 2 - - - - - -
Rate of return - - - - - -
EPS 2 -0.0226 -0.051 0.0831 -0.0169 -0.0221 0.000862
Distribution rate - - - - - -
Net sales 1 0.005724 -1.69 95.77 0.088 0.359 1.88
EBITDA - - - - - -
EBIT 1 -1.483 -3.371 5.492 -1.658 -1.457 0.078
Net income 1 -1.491 -3.371 5.492 -1.189 -1.461 0.057
Net Debt 1 -0.2513 -0.1931 0.697 0.764 -0.211 -0.222
Reference price 2 0.8200 1.6500 1.3600 0.7000 0.6600 0.9100
Nbr of stocks (in thousands) 66,069 66,069 66,069 66,069 66,069 66,069
Announcement Date 8/24/20 8/26/21 8/29/22 9/4/23 9/5/24 8/25/25
1INR in Million2INR
Estimates


P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 581K
43.41x6.99x32.93x - 592M
Average 43.41x 6.99x 32.93x 296.22M
Weighted average by Cap. 43.41x 6.99x 32.93x

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


  1. Stock Market
  2. Stocks
  3. 531681 Stock
  4. Valuation Amerise Biosciences Limited